These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 26228379)

  • 1. Lenalidomide and secondary acute lymphoblastic leukemia: a case series.
    Tan M; Fong R; Lo M; Young R
    Hematol Oncol; 2017 Mar; 35(1):130-134. PubMed ID: 26228379
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute lymphoblastic leukemia developing during maintenance therapy with lenalidomide in a patient with multiple myeloma.
    García-Muñoz R; Robles-de-Castro D; Muñoz-Rodríguez A; Rabasa P
    Leuk Lymphoma; 2013 Dec; 54(12):2753-5. PubMed ID: 23488662
    [No Abstract]   [Full Text] [Related]  

  • 3. B-cell acute lymphoblastic leukemia in an elderly man with plasma cell myeloma and long-term exposure to thalidomide and lenalidomide: a case report and literature review.
    Sinit RB; Hwang DG; Vishnu P; Peterson JF; Aboulafia DM
    BMC Cancer; 2019 Nov; 19(1):1147. PubMed ID: 31775673
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment-Associated Acute Lymphoblastic Leukemia Following Autologous Hematopoietic Stem Cell Transplant and Lenalidomide Maintenance in Patients With Multiple Myeloma.
    Crosby J; Erzuah T; Haider M; Smith F; Ganti S; Monohan G; Elsouiedi R
    J Investig Med High Impact Case Rep; 2022; 10():23247096221133204. PubMed ID: 36300378
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A rare case of nasopharyngeal carcinoma in a patient with multiple myeloma after treatment by lenalidomide.
    Xu G; Wang B; Yang M; Qian W
    Int J Clin Exp Pathol; 2015; 8(11):15025-9. PubMed ID: 26823839
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A rare case of acute lymphoblastic leukemia in a patient with light chain (AL) amyloidosis treated with lenalidomide.
    Nair R; Gheith S; Popescu D; Agostino NM
    Int J Clin Exp Pathol; 2014; 7(5):2683-9. PubMed ID: 24966987
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Classical hodgkin lymphoma as de novo B-cell malignancy after treatment of multiple myeloma in the pre-lenalidomide era.
    Zago M; Adam P; Goldschmidt H; Fend F; Kanz L; Weisel K
    Clin Lymphoma Myeloma Leuk; 2014 Feb; 14(1):e7-e11. PubMed ID: 24169269
    [No Abstract]   [Full Text] [Related]  

  • 8. Lenalidomide in multiple myeloma.
    Kim Y; Schmidt-Wolf IG
    Expert Rev Anticancer Ther; 2015 May; 15(5):491-7. PubMed ID: 25843431
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Three patients with multiple myeloma developing secondary lymphoblastic leukemia: case reports and review of the literature.
    Junxun L; Junru L; Meilan C; Chujia L; Shaoqian C; Jieyu Z; Zhuangjian Y; Fan Z; Juan O; Jing C; Juan L
    Tumori; 2016 Nov; 102(Suppl. 2):. PubMed ID: 26166219
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute myelofibrosis and acute lymphoblastic leukemia in an elderly patient with previously treated multiple myeloma.
    Gonzalez MM; Kidd L; Quesada J; Nguyen N; Chen L
    Ann Clin Lab Sci; 2013; 43(2):176-80. PubMed ID: 23694793
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Secondary or concomitant neoplasms among adults diagnosed with acute lymphoblastic leukemia and treated according to the LALA-87 and LALA-94 trials.
    Tavernier E; Le QH; de Botton S; Dhédin N; Bulabois CE; Reman O; Vey N; Lhéritier V; Dombret H; Thomas X
    Cancer; 2007 Dec; 110(12):2747-55. PubMed ID: 17963265
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lenalidomide maintenance after stem-cell transplantation for multiple myeloma.
    Attal M; Lauwers-Cances V; Marit G; Caillot D; Moreau P; Facon T; Stoppa AM; Hulin C; Benboubker L; Garderet L; Decaux O; Leyvraz S; Vekemans MC; Voillat L; Michallet M; Pegourie B; Dumontet C; Roussel M; Leleu X; Mathiot C; Payen C; Avet-Loiseau H; Harousseau JL;
    N Engl J Med; 2012 May; 366(19):1782-91. PubMed ID: 22571202
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Second primary malignancies with lenalidomide therapy for newly diagnosed myeloma: a meta-analysis of individual patient data.
    Palumbo A; Bringhen S; Kumar SK; Lupparelli G; Usmani S; Waage A; Larocca A; van der Holt B; Musto P; Offidani M; Petrucci MT; Evangelista A; Zweegman S; Nooka AK; Spencer A; Dimopoulos MA; Hajek R; Cavo M; Richardson P; Lonial S; Ciccone G; Boccadoro M; Anderson K; Barlogie B; Sonneveld P; McCarthy PL
    Lancet Oncol; 2014 Mar; 15(3):333-42. PubMed ID: 24525202
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute Renal Failure Associated with Lenalidomide Treatment in Multiple Myeloma: A Rare Occurrence?
    Kreiniz N; Khateeb A; Gino-Moor S; Polliack A; Tadmor T
    Anticancer Res; 2016 Jun; 36(6):2889-92. PubMed ID: 27272801
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Update on second primary malignancies in multiple myeloma: a focused review.
    Landgren O; Mailankody S
    Leukemia; 2014 Jul; 28(7):1423-6. PubMed ID: 24418993
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Connect MM® - the Multiple Myeloma Disease Registry: incidence of second primary malignancies in patients treated with lenalidomide.
    Rifkin RM; Abonour R; Shah JJ; Mehta J; Narang M; Terebelo H; Gasparetto C; Toomey K; Hardin JW; Lu JJ; Kenvin L; Srinivasan S; Knight R; Nagarwala Y; Durie BG
    Leuk Lymphoma; 2016 Sep; 57(9):2228-31. PubMed ID: 26766599
    [No Abstract]   [Full Text] [Related]  

  • 17. Acute lymphoblastic leukemia as a clonally unrelated second primary malignancy after multiple myeloma.
    Aldoss I; Capelletti M; Park J; Pistofidis RS; Pillai R; Stiller T; Sanchez JF; Forman SJ; Ghobrial IM; Krishnan A
    Leukemia; 2019 Jan; 33(1):266-270. PubMed ID: 30026571
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapy-related myelodysplastic syndrome/acute leukemia after multiple myeloma in the era of novel agents.
    Gertz MA; Terpos E; Dispenzieri A; Kumar S; Shah RA; Orlowski R; Kastritis E; Dimopoulos MA; Shah J
    Leuk Lymphoma; 2015 Jun; 56(6):1723-6. PubMed ID: 25284489
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Population pharmacokinetics of lenalidomide in patients with B-cell malignancies.
    Hughes JH; Phelps MA; Upton RN; Reuter SE; Gao Y; Byrd JC; Grever MR; Hofmeister CC; Marcucci G; Blum W; Blum KA; Foster DJR
    Br J Clin Pharmacol; 2019 May; 85(5):924-934. PubMed ID: 30672004
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The risk of secondary primary malignancies after therapy for multiple myeloma.
    Areethamsirikul N; Reece DE
    Leuk Lymphoma; 2015; 56(11):3012-21. PubMed ID: 25947036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.